Elekta Rises to Meet Demand for Cancer Care Technology in Asia Pacific Region

Four major Asia Pacific exhibitions in October to showcase cancer management solutions

Hong Kong — Tuesday, October 5, 2010

Countries in the Asia-Pacific region—especially China, India, and the rapidly developing territories of Southeast Asia—are making unprecedented healthcare investments to serve their large populations, increasing the demand for new care capacity, particularly for patients with cancer. In October, Elekta will show how Asian-Pacific nations can satisfy their technology requirements to manage cancer at four exhibitions:
 

  • The 64th China International Medical Equipment Fair (CMEF) , October 12-15 in Shenyang, China
  • The 2nd Chinese Society of Therapeutic Radiology and Oncology and Sino-American Network for Therapeutic Radiology and Oncology (CSTRO/SANTRO ) joint symposium and meeting, October 14-16 in Hangzhou, China
  • The Royal Australian and New Zealand College of Radiologists (RANZCR ) 61st Annual Scientific Meeting (ASM), October 14-17 in Perth, Western Australia
  • The 10th meeting of the Asia-Oceania Congress of Medical Physics (AOCMP ), October 15-17 in Taipei, Taiwan


“Asia-Pacific countries are boldly meeting the healthcare challenges of their residents, many of whom are living longer and utilizing needed medical care, particularly treatment for cancer,” says Ian Alexander, Executive Vice President of Elekta’s Asia Pacific. “Accordingly, clinics and medical centers in this region are accelerating their acquisition of technology resources to create new capacity and improve access to radiation therapy and cancer care. Elekta is redoubling its efforts to ensure we can address these countries’ healthcare needs.”

A rapidly growing market
Illustrating the demand for healthcare capacity, China will invest $123 billion USD for reform, under which 90 percent of China’s population will be covered by its healthcare system. In addition, 30,000 new hospitals, clinics and healthcare centers are expected to be built. In India, the hospital market is expanding at yearly rate of more than 10 percent in recent years, and is expected to reach $145 billion USD by 2017. Major advances also have been made in Singapore, South Korea, Taiwan and Australia.

“Elekta has invested heavily in many Asia-Pacific countries to match the pace of their growth,” Alexander adds. “This includes investments in our distribution capacity and customer service, in addition to IT infrastructure, support and customer training courses.”

Exhibition highlights
Among the solutions Elekta will highlight at the three Asia-Pacific exhibits are:
 

  • Elekta Compact™ cost-effective, versatile linear accelerator. Designed to accept new features and functions as department needs grow, Compact provides a wide range of treatment techniques.
  • Elekta VMAT (Volumetric Modulated Arc Therapy) next generation arc therapy technique. Using dynamic gantry arcs, Elekta VMAT can result in significantly reduced treatment times, while providing a more personalized treatment.
  • Advanced IGRT solutions, including:
  • Intuity™ image guidance for tumors and critical structures. Building on Elekta’s XVI imaging technology, Intuity offers superior image quality combined with the largest available image size.
  • Symmetry™ respiratory motion management for lung tumor treatment. Symmetry visualizes moving tumors during treatment, enabling clinicians to reduce margins, account for baseline shifts and employ uninterrupted treatment delivery while the patient breathes.
  • Clarity*™ soft tissue visualization. Capable of integrating with any linac platform, Clarity facilitates breast and prostate soft tissue visualization for planning and patient set-up. Clarity seamlessly integrates within existing clinical workflows.
  • MOSAIQ® oncology information and image enabled EMR system. Streamlining the entire therapy workflow from diagnosis and staging, through planning, treatment , follow up and long-term survivorship, MOSAIQ now supports the Chinese language.
  • Radiation treatment planning tools, including Monaco®, XiO® and Atlas-based Autosegmentation that enhance workflow and help make the planning process easier, more straightforward and clinically reliable.

For more information on Elekta’s cancer management solutions, visit

www.elekta.com/oncology

.



* Clarity is not for sale or distribution in all regions. Please contact your local Elekta representative or authorized distributor for further details.

 

###

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

Press Releases

For further information, please contact

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Email: stina.thorman@elekta.com
Time zone: CET: Central European Time

Michelle Lee Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time